IDEAS home Printed from https://ideas.repec.org/r/eee/jhecon/v14y1995i2p171-189.html
   My bibliography  Save this item

The friction cost method for measuring indirect costs of disease

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. P. Beutels & W. J. Edmunds & R. D. Smith, 2008. "Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern," Health Economics, John Wiley & Sons, Ltd., vol. 17(11), pages 1317-1322.
  2. Gudrun Biffl & Thomas Leoni & Christine Mayrhuber, 2009. "Arbeitsplatzbelastungen, arbeitsbedingte Krankheiten und Invalidität," WIFO Studies, WIFO, number 35901, April.
  3. J. Jarl & U.-G. Gerdtham, 2012. "Does drinking affect long-term sickness absence? A sample selection approach correcting for employment and accounting for drinking history," Applied Economics, Taylor & Francis Journals, vol. 44(22), pages 2811-2825, August.
  4. Axel Svedbom & Johan Dalén & Moa Ivergård & Rebekah H. Borse & Christopher M. Black & Karin Luttropp & Sumesh Kachroo, 2020. "The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 45-54, February.
  5. Geke Romijn & Neeltje Batelaan & Jeroen Koning & Anton van Balkom & Aart de Leeuw & Friederike Benning & Leona Hakkaart van Roijen & Heleen Riper, 2021. "Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week ," PLOS ONE, Public Library of Science, vol. 16(11), pages 1-20, November.
  6. Backman, Mikaela & Gabe, Todd & Mellander, Charlotta, 2016. "Effects of Human Capital on the Growth and Survival of Swedish Businesses," Journal of Regional Analysis and Policy, Mid-Continent Regional Science Association, vol. 46(1).
  7. Thomas DeLeire & Willard Manning, 2004. "Labor market costs of illness: prevalence matters," Health Economics, John Wiley & Sons, Ltd., vol. 13(3), pages 239-250, March.
  8. L. M. Peña-Longobardo & J. Oliva-Moreno & C. Fernández-Rodriguez, 2023. "The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: a ten-year analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(8), pages 1271-1283, November.
  9. Tobias Effertz & Susanne Engel & Frank Verheyen & Roland Linder, 2016. "The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(9), pages 1141-1158, December.
  10. Iris Arends & Ute Bültmann & Willem van Rhenen & Henk Groen & Jac J L van der Klink, 2013. "Economic Evaluation of a Problem Solving Intervention to Prevent Recurrent Sickness Absence in Workers with Common Mental Disorders," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-1, August.
  11. Siri Fauli & Geir Thue, 2008. "Economic consequences of near-patient test results: the case of tests for the Helicobacter Pylori bacterium in dyspepsia," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(3), pages 221-228, August.
  12. Zhang, Wei & Bansback, Nick & Anis, Aslam H., 2011. "Measuring and valuing productivity loss due to poor health: A critical review," Social Science & Medicine, Elsevier, vol. 72(2), pages 185-192, January.
  13. Kristian Sundström & Helene Wahlström & Sofie Ivarsson & Susanna Sternberg Lewerin, 2014. "Economic Effects of Introducing Alternative Salmonella Control Strategies in Sweden," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-10, May.
  14. Werner Brouwer & Samare Huls & Ayesha Sajjad & Tim Kanters & Leona Hakkaart-van Roijen & Job Exel, 2022. "In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era," PharmacoEconomics, Springer, vol. 40(1), pages 7-11, January.
  15. Simon Wieser & Bruno Horisberger & Sara Schmidhauser & Claudia Eisenring & Urs Brügger & Andreas Ruckstuhl & Jürg Dietrich & Anne Mannion & Achim Elfering & Özgür Tamcan & Urs Müller, 2011. "Cost of low back pain in Switzerland in 2005," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(5), pages 455-467, October.
  16. Carrasco, Luis R & Lee, Linda K & Lee, Vernon J & Ooi, Eng Eong & Shepard, Donald S & Thein, Tun L & Gan, Victor & Cook, Alex R & Lye, David & Ng, Lee Ching & Leo, Yee Sin, 2011. "Economic Impact of Dengue Illness and the Cost-Effectiveness of Future Vaccination Programs in Singapore," MPRA Paper 57761, University Library of Munich, Germany.
  17. Vittoria Colamesta & Andrea Tamburrano & Andrea Barbara & Andrea Gentili & Daniele Ignazio La Milia & Filippo Berloco & Americo Cicchetti & Daniele Piacentini & Roberta Galluzzi & Sergio Riccardo Mast, 2019. "Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study," PLOS ONE, Public Library of Science, vol. 14(11), pages 1-9, November.
  18. Marco Hafner & Erez Yerushalmi & Fredrik L. Andersson & Teodor Burtea, 2023. "Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia," Health Economics, John Wiley & Sons, Ltd., vol. 32(3), pages 654-674, March.
  19. Hanna Waart & Johanna M. Dongen & Wim H. Harten & Martijn M. Stuiver & Rosalie Huijsmans & Jeannette A. J. H. Hellendoorn-van Vreeswijk & Gabe S. Sonke & Neil K. Aaronson, 2018. "Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(6), pages 893-904, July.
  20. John A. Nyman, 2012. "Productivity Costs Revisited: Toward A New Us Policy," Health Economics, John Wiley & Sons, Ltd., vol. 21(12), pages 1387-1401, December.
  21. Susana Monge & Roan Pijnacker & Wilfrid van Pelt & Eelco Franz & Laetitia M Kortbeek & Marie-Josée J Mangen, 2019. "Accounting for long-term manifestations of Cryptosporidium spp infection in burden of disease and cost-of-illness estimations, the Netherlands (2013–2017)," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-16, March.
  22. Maria Michela Gianino & Gianfranco Politano & Antonio Scarmozzino & Michela Stillo & Viola Amprino & Stefano Di Carlo & Alfredo Benso & Carla Maria Zotti, 2019. "Cost of Sickness Absenteeism during Seasonal Influenza Outbreaks of Medium Intensity among Health Care Workers," IJERPH, MDPI, vol. 16(5), pages 1-11, March.
  23. Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2023. "Productivity and quality-adjusted life years: QALYs, PALYs and beyond," Working Papers 11-2023, Copenhagen Business School, Department of Economics.
  24. Ghislaine van Mastrigt & Caroline van Heugten & Anne Visser-Meily & Leonarda Bremmers & Silvia Evers, 2022. "Estimating the Burden of Stroke: Two-Year Societal Costs and Generic Health-Related Quality of Life of the Restore4Stroke Cohort," IJERPH, MDPI, vol. 19(17), pages 1-15, September.
  25. Mark V. Pauly & Sean Nicholson & Judy Xu & Dan Polsky & Patricia M. Danzon & James F. Murray & Marc L. Berger, 2002. "A general model of the impact of absenteeism on employers and employees," Health Economics, John Wiley & Sons, Ltd., vol. 11(3), pages 221-231, April.
  26. Yinong Young-Xu & Robertus van Aalst & Ellyn Russo & Jason K H Lee & Ayman Chit, 2017. "The Annual Burden of Seasonal Influenza in the US Veterans Affairs Population," PLOS ONE, Public Library of Science, vol. 12(1), pages 1-15, January.
  27. Allison Larg & John Moss, 2011. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 29(8), pages 653-671, August.
  28. Henry Zheng & Fred Ehrlich & Janaki Amin, 2010. "Productivity loss resulting from coronary heart disease in Australia," Applied Health Economics and Health Policy, Springer, vol. 8(3), pages 179-189, May.
  29. Tom Duchemin & Mounia N Hocine, 2020. "Modeling sickness absence data: A scoping review," PLOS ONE, Public Library of Science, vol. 15(9), pages 1-10, September.
  30. Pierre Kopp & Marysia Ogrodnik, 2017. "The social cost of drugs in France in 2010," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(7), pages 883-892, September.
  31. Anna Miquel-Cases & Valesca P Retèl & Bianca Lederer & Gunter von Minckwitz & Lotte M G Steuten & Wim H van Harten, 2016. "Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients," PLOS ONE, Public Library of Science, vol. 11(4), pages 1-13, April.
  32. Tobias Effertz & Frank Verheyen & Roland Linder, 2017. "The costs of hazardous alcohol consumption in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(6), pages 703-713, July.
  33. Oi Ling Siu & Cary L. Cooper & Lara C. Roll & Carol Lo, 2020. "Occupational Stress and Its Economic Cost in Hong Kong: The Role of Positive Emotions," IJERPH, MDPI, vol. 17(22), pages 1-22, November.
  34. Klose, Thomas, 1999. "The contingent valuation method in health care," Health Policy, Elsevier, vol. 47(2), pages 97-123, May.
  35. Andersson, Emelie & Eliasson, Björn & Steen Carlsson, Katarina, 2022. "Current and future costs of obesity in Sweden," Health Policy, Elsevier, vol. 126(6), pages 558-564.
  36. Foster, Nicola & Vassall, Anna & Cleary, Susan & Cunnama, Lucy & Churchyard, Gavin & Sinanovic, Edina, 2015. "The economic burden of TB diagnosis and treatment in South Africa," Social Science & Medicine, Elsevier, vol. 130(C), pages 42-50.
  37. Oliver Fritz & Peter Mayerhofer & Reinhard Haller & Gerhard Streicher & Florian Bachner & Herwig Ostermann, 2013. "Die regionalwirtschaftlichen Effekte der österreichischen Krankenanstalten," WIFO Studies, WIFO, number 46672, April.
  38. Johan Jarl & Pia Johansson & Antonina Eriksson & Mimmi Eriksson & Ulf-G. Gerdtham & Örjan Hemström & Klara Selin & Leif Lenke & Mats Ramstedt & Robin Room, 2008. "The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 9(4), pages 351-360, November.
  39. Michal Jakubczyk & Beata Kon, 2016. "The impact of firms' expectations & adjustments on the productivity cost of illness," KAE Working Papers 2016-008, Warsaw School of Economics, Collegium of Economic Analysis.
  40. B. Svendsen & K.-M. Myhr & H. Nyland & J. Aarseth, 2012. "The cost of multiple sclerosis in Norway," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(1), pages 81-91, February.
  41. Klas Kellerborg & Werner Brouwer & Pieter Baal, 2020. "Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1329-1350, December.
  42. Ilias Goranitis & Leana Bellanca & Amanda J Daley & Adele Thomas & Helen Stokes-Lampard & Andrea K Roalfe & Sue Jowett, 2017. "Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial," PLOS ONE, Public Library of Science, vol. 12(9), pages 1-15, September.
  43. Andrzej Torój, 2013. "Why Don’t Blanchard-Kahn ever "Catch" Flu? And How it Matters for Measuring Indirect Cost of Epidemics in DSGE Framework," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, vol. 5(3), pages 185-206, September.
  44. Marie Kruse & Jan Sørensen & Dorte Gyrd-Hansen, 2012. "Future costs in cost-effectiveness analysis: an empirical assessment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(1), pages 63-70, February.
  45. Judith Bosmans & Oscar Brook & Hein Hout & Martine Bruijne & Hugo Nieuwenhuyse & Lex Bouter & Wim Stalman & Maurits Tulder, 2007. "Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants," PharmacoEconomics, Springer, vol. 25(1), pages 25-37, January.
  46. Antonis Targoutzidis, 2018. "Some adjustments to the human capital and the friction cost methods," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(9), pages 1225-1228, December.
  47. Mangen, Marie-Josee J. & Havelaar, Arie H. & de Wit, G. Ardine & Bernsen, Rob A.J.A.M. & van Koningsveld, Rinske, 2004. "Estimating the Costs and the Disease Burden Associated With Campylobacter Infections and Sequelae in the Netherlands," 84th Seminar, February 8-11, 2004, Zeist, The Netherlands 24985, European Association of Agricultural Economists.
  48. Anne Tiainen & Clas Rehnberg, 2010. "The Economic Burden of Psychiatric Disorders in Sweden," International Journal of Social Psychiatry, , vol. 56(5), pages 515-526, September.
  49. Chima, Reginald Ikechukwu & Goodman, Catherine A. & Mills, Anne, 2003. "The economic impact of malaria in Africa: a critical review of the evidence," Health Policy, Elsevier, vol. 63(1), pages 17-36, January.
  50. Silke B. Wolfenstetter & Christina M. Wenig, 2010. "Economic Evaluation and Transferability of Physical Activity Programmes in Primary Prevention: A Systematic Review," IJERPH, MDPI, vol. 7(4), pages 1-27, April.
  51. Mangen, Marie-Josee J. & Havelaar, Arie H. & Nauta, Maarten J. & de Koeijer, Aline A. & de Wit, G. Ardine, 2005. "Controlling Campylabacter in the Chicken Meat Chain: A Cost-Utility Analysis," 2005 International Congress, August 23-27, 2005, Copenhagen, Denmark 24763, European Association of Agricultural Economists.
  52. Tilling, C & Krol, M & Tsuchiya, A & Brazier, J & van Exel, J & Brouwer, W, 2009. "The impact of losses in income due to ill health: does the EQ-5D reflect lost earnings?," MPRA Paper 29837, University Library of Munich, Germany.
  53. Marie‐Josée J. Mangen & Michael B. Batz & Annemarie Käsbohrer & Tine Hald & J. Glenn Morris & Michael Taylor & Arie H. Havelaar, 2010. "Integrated Approaches for the Public Health Prioritization of Foodborne and Zoonotic Pathogens," Risk Analysis, John Wiley & Sons, vol. 30(5), pages 782-797, May.
  54. Pavel, Md Sadik & Chakrabarty, Sayan & Gow, Jeff, 2015. "Cost of illness for outpatients attending public and private hospitals in Bangladesh," MPRA Paper 74491, University Library of Munich, Germany, revised 03 Sep 2016.
  55. P. Beutels & W. J. Edmunds & R. D. Smith, 2008. "Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern," Health Economics, John Wiley & Sons, Ltd., vol. 17(11), pages 1317-1322, November.
  56. Juan Oliva & Félix Lobo & Julio López-Bastida & Néboa Zozaya & Rosa Romay, 2005. "Indirect costs of cervical and breast cancers in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(4), pages 309-313, December.
  57. Karin H. M. Jacob‐Tacken & Marc A. Koopmanschap & Willem Jan Meerding & Johan L. Severens, 2005. "Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes," Health Economics, John Wiley & Sons, Ltd., vol. 14(5), pages 435-443, May.
  58. Johannesson, Magnus & Karlsson, Goran, 1997. "The friction cost method: A comment," Journal of Health Economics, Elsevier, vol. 16(2), pages 249-255, April.
  59. Kyra Kneis & Afschin Gandjour, 2009. "Economic evaluation of Sinfrontal®in the treatment of acute maxillary sinusitis in adults," Applied Health Economics and Health Policy, Springer, vol. 7(3), pages 181-191, September.
  60. Paul Hanly & Rebecca Maguire & Frances Drummond & Linda Sharp, 2019. "Variation in the methodological approach to productivity cost valuation: the case of prostate cancer," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1399-1408, December.
  61. Marie-Josée J. Mangen & G. Ardine de Wit & Arie H. Havelaar, 2007. "Economic analysis of Campylobacter control in the dutch broiler meat chain," Agribusiness, John Wiley & Sons, Ltd., vol. 23(2), pages 173-192.
  62. Antoine Bailly & Et Carole Chichignoud, 2006. "Risques Et Santé/Riesgos Y Salud," Estudios de Economia Aplicada, Estudios de Economia Aplicada, vol. 24, pages 865-874, Diciembre.
  63. Berta Rivera & Bruno Casal & Luis Currais, 2015. "The social cost of illegal drug consumption in Spain: identifying and quantifying its elements," Working Papers. Collection B: Regional and sectoral economics 1503, Universidade de Vigo, GEN - Governance and Economics research Network.
  64. Gravelle, Hugh & Schroyen, Fred, 2020. "Optimal hospital payment rules under rationing by waiting," Journal of Health Economics, Elsevier, vol. 70(C).
  65. Luis R Carrasco & Linda K Lee & Vernon J Lee & Eng Eong Ooi & Donald S Shepard & Tun L Thein & Victor Gan & Alex R Cook & David Lye & Lee Ching Ng & Yee Sin Leo, 2011. "Economic Impact of Dengue Illness and the Cost-Effectiveness of Future Vaccination Programs in Singapore," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 5(12), pages 1-9, December.
  66. Spierdijk, Laura & van Lomwel, Gijsbert & Peppelman, Wilko, 2009. "The determinants of sick leave durations of Dutch self-employed," Journal of Health Economics, Elsevier, vol. 28(6), pages 1185-1196, December.
  67. Alison Pearce & Paul Hanly & Aileen Timmons & Paul Walsh & Ciaran O’Neill & Eleanor O’Sullivan & Rachael Gooberman-Hill & Audrey Thomas & Pamela Gallagher & Linda Sharp, 2015. "Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches," Applied Health Economics and Health Policy, Springer, vol. 13(4), pages 359-367, August.
  68. Jesse Kigozi & Sue Jowett & Martyn Lewis & Pelham Barton & Joanna Coast, 2016. "Estimating productivity costs using the friction cost approach in practice: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 31-44, January.
  69. Skatun, John Douglas, 2003. "Take some days off, why don't you?: Endogenous sick leave and pay," Journal of Health Economics, Elsevier, vol. 22(3), pages 379-402, May.
  70. Carrasco, L R & Lee, V J & Chen, M I & Matchar, D B & Thompson, J P & Cook, A R, 2011. "Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective," MPRA Paper 57763, University Library of Munich, Germany.
  71. Jeff Richardson & Stuart Peacock & Angelo Iezzi, 2009. "Do quality-adjusted life years take account of lost income? Evidence from an Australian survey," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 103-109, February.
  72. Bengt Liljas, 2010. "On the welfare theoretic foundation of cost-effectiveness analysis—the case when survival is not affected," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 11(1), pages 5-13, February.
  73. Koopmanschap, Marc A. & Rutten, Frans F. H. & van Ineveld, B. Martin & van Roijen, Leona, 1997. "Reply to Johanneson's and Karlsson's comment," Journal of Health Economics, Elsevier, vol. 16(2), pages 257-259, April.
  74. Marieke Krol & Jocé Papenburg & Marc Koopmanschap & Werner Brouwer, 2011. "Do Productivity Costs Matter?," PharmacoEconomics, Springer, vol. 29(7), pages 601-619, July.
  75. Anna K. Lugnér & Sido D. Mylius & Jacco Wallinga, 2010. "Dynamic versus static models in cost‐effectiveness analyses of anti‐viral drug therapy to mitigate an influenza pandemic," Health Economics, John Wiley & Sons, Ltd., vol. 19(5), pages 518-531, May.
  76. Johan Liwing & Christina Wiktorin & Wilhelmus JA Grooten & Teresia Nyman & Magnus Svartengren, 2009. "High Costs For Co-Occurrence of Neck/Shoulder and Low Back Disorders in Sweden," Ege Academic Review, Ege University Faculty of Economics and Administrative Sciences, vol. 9(3), pages 1017-1033.
  77. Jonathan Karnon & Jill Carlton & Carolyn Czoski-Murray & Kevin Smith, 2009. "Informing disinvestment through cost-effectiveness modelling," Applied Health Economics and Health Policy, Springer, vol. 7(1), pages 1-9, March.
  78. Marieke Krol & Werner Brouwer, 2014. "How to Estimate Productivity Costs in Economic Evaluations," PharmacoEconomics, Springer, vol. 32(4), pages 335-344, April.
  79. Hoeijenbos, Margreet & Bekkering, Trudy & Lamers, Leida & Hendriks, Erik & van Tulder, Maurits & Koopmanschap, Marc, 2005. "Cost-effectiveness of an active implementation strategy for the Dutch physiotherapy guideline for low back pain," Health Policy, Elsevier, vol. 75(1), pages 85-98, December.
  80. Pascal Crépey & Esther Redondo & Javier Díez-Domingo & Raúl Ortiz de Lejarazu & Federico Martinón-Torres & Ángel Gil de Miguel & Juan Luis López-Belmonte & Fabián P Alvarez & Hélène Bricout & Míriam S, 2020. "From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-19, May.
  81. Brouwer, W. B. F. & Koopmanschap, M. A. & Rutten, F. F. H., 1999. "Productivity losses without absence: measurement validation and empirical evidence," Health Policy, Elsevier, vol. 48(1), pages 13-27, July.
  82. Beata Gavurova & Miriama Tarhanicova, 2021. "Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption," IJERPH, MDPI, vol. 18(9), pages 1-25, May.
  83. Stefanie Thönnes & Stefan Pichler, 2019. "Sickness absence and unemployment revisited," Working Papers Dissertations 53, Paderborn University, Faculty of Business Administration and Economics.
  84. Hanna Gyllensten & Michael Wiberg & Kristina Alexanderson & Anders Norlund & Emilie Friberg & Jan Hillert & Olivia Ernstsson & Petter Tinghög, 2018. "Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(3), pages 435-446, April.
  85. Jackie, Yenerall & Wen, You & George, Davis & Paul, Estabrooks, 2015. "Examining Ways to Handle Non-Random Missingness in CEA through Econometric and Statistics Lenses," 2015 AAEA & WAEA Joint Annual Meeting, July 26-28, San Francisco, California 205690, Agricultural and Applied Economics Association.
  86. Robin de Vries & Mirjam Kretzschmar & Joop F P Schellekens & Florens G A Versteegh & Tjalke A Westra & John J Roord & Maarten J Postma, 2010. "Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model," PLOS ONE, Public Library of Science, vol. 5(10), pages 1-11, October.
  87. Annie Hawton & James Shearer & Elizabeth Goodwin & Colin Green, 2013. "Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis," Applied Health Economics and Health Policy, Springer, vol. 11(4), pages 331-341, August.
  88. James Shearer & Paul McCrone & Renee Romeo, 2016. "Economic Evaluation of Mental Health Interventions: A Guide to Costing Approaches," PharmacoEconomics, Springer, vol. 34(7), pages 651-664, July.
  89. Cam Donaldson & Stephen Birch & Amiram Gafni, 2002. "The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes," Health Economics, John Wiley & Sons, Ltd., vol. 11(1), pages 55-70, January.
  90. Dominic Trépel, 2011. "Informal Cost of Dementia Care – A Proxy-Good Valuation in Ireland," The Economic and Social Review, Economic and Social Studies, vol. 42(4), pages 479-503.
  91. Mansdotter, Anna & Lindholm, Lars & Winkvist, Anna, 2007. "Paternity leave in Sweden--Costs, savings and health gains," Health Policy, Elsevier, vol. 82(1), pages 102-115, June.
  92. Carmen Herrero Blanco & Juan D. Moreno Ternero, 2004. "Generalized Cost-Analysis Of Screening Programs," Working Papers. Serie AD 2004-18, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
  93. Lesong Conteh & Edith Patouillard & Margaret Kweku & Rosa Legood & Brian Greenwood & Daniel Chandramohan, 2010. "Cost Effectiveness of Seasonal Intermittent Preventive Treatment Using Amodiaquine & Artesunate or Sulphadoxine-Pyrimethamine in Ghanaian Children," PLOS ONE, Public Library of Science, vol. 5(8), pages 1-11, August.
  94. Werner B. F. Brouwer & Marc A. Koopmanschap & Frans F. H. Rutten, 1997. "Productivity Costs Measurement Through Quality of Life? A Response to the Recommendation of the Washington Panel," Health Economics, John Wiley & Sons, Ltd., vol. 6(3), pages 253-259, May.
  95. Barbara Barrett & Waquas Waheed & Simone Farrelly & Max Birchwood & Graham Dunn & Clare Flach & Claire Henderson & Morven Leese & Helen Lester & Max Marshall & Diana Rose & Kim Sutherby & George Szmuk, 2013. "Randomised Controlled Trial of Joint Crisis Plans to Reduce Compulsory Treatment for People with Psychosis: Economic Outcomes," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-11, November.
  96. Ben F M Wijnen & Bea Hemmen & Ans I E Bouman & Henk van de Meent & Ton Ambergen & Peter R G Brink & Henk A M Seelen & Silvia M A A Evers, 2019. "Cost-effectiveness of an integrated 'fast track' rehabilitation service for multi-trauma patients: A non-randomized clinical trial in the Netherlands," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-17, March.
  97. Carmen Herrero & Juan D. Moreno‐Ternero, 2009. "Estimating production costs in the economic evaluation of health‐care programs," Health Economics, John Wiley & Sons, Ltd., vol. 18(1), pages 21-35, January.
  98. Nancy Thiry & Philippe Beutels & Pierre Damme & Eddy Doorslaer, 2003. "Economic Evaluations of Varicella Vaccination Programmes," PharmacoEconomics, Springer, vol. 21(1), pages 13-38, January.
  99. Berta Rivera & Bruno Casal & Luis Currais, 2017. "Crisis, suicide and labour productivity losses in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(1), pages 83-96, January.
  100. Edward Wilson & Erika Sims & Stanley Musgrave & Lee Shepstone & Annie Blyth & Jamie Murdoch & H. Mugford & Elizabeth Juniper & Jon Ayres & Stephanie Wolfe & Daryl Freeman & Richard Gilbert & Ian Harve, 2010. "Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy," PharmacoEconomics, Springer, vol. 28(7), pages 585-595, July.
  101. Mandel Michael & Anita Bálint & Barbara Lovász & László Gulácsi & Bálint Strbák & Petra Golovics & Klaudia Farkas & Zsuzsanna Kürti & Blanka Szilágyi & Anna Mohás & Tamás Molnár & Péter Lakatos, 2014. "Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(1), pages 121-128, May.
  102. Versteegh, M.M. & Brouwer, W.B.F., 2016. "Patient and general public preferences for health states: A call to reconsider current guidelines," Social Science & Medicine, Elsevier, vol. 165(C), pages 66-74.
  103. Magnus Johannesson & David Meltzer, 1998. "Editorial: Some reflections on cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 7(1), pages 1-7, February.
  104. Hanly Paul & Pearce Alison & Sharp Linda, 2017. "Cancer and productivity loss in the Irish economy: an employer’s perspective," The Irish Journal of Management, Sciendo, vol. 36(1), pages 5-20.
  105. Carola Lingua & Giulia Crespi & Cristina Becchio & Stefano Paolo Corgnati, 2023. "Designing IAQ-Resilient Post-Pandemic Buildings," Sustainability, MDPI, vol. 15(3), pages 1-17, January.
  106. Brouwer, Werner B. F. & Koopmanschap, Marc A., 2000. "On the economic foundations of CEA. Ladies and gentlemen, take your positions!," Journal of Health Economics, Elsevier, vol. 19(4), pages 439-459, July.
  107. Eric D. Carlström & Elisabeth Hansson Olofsson & Lars-Eric Olsson & Jan Nyman & Inga-Lill Koinberg, 2017. "The unannounced patient in the corridor: trust, friction and person-centered care," International Journal of Health Planning and Management, Wiley Blackwell, vol. 32(1), pages 1-16, January.
  108. Ina Rissanen & Leena Ala-Mursula & Iiro Nerg & Marko Korhonen, 2021. "Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 531-545, June.
  109. Arthur E. Attema & Anna K. Lugnér & Talitha L. Feenstra, 2010. "Investment in antiviral drugs: a real options approach," Health Economics, John Wiley & Sons, Ltd., vol. 19(10), pages 1240-1254, October.
  110. Mathias Lidgren & Nils Wilking & Bengt Jönsson, 2007. "Cost of breast cancer in Sweden in 2002," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(1), pages 5-15, March.
  111. Clive Pritchard;Martin Sculpher, 2000. "Productivity Costs: Principles and Practice in Economic Evaluation," Monograph 000464, Office of Health Economics.
  112. Hassan Serrier & Hélène Sultan-Taieb & Danièle Luce & Sophie Bejean, 2014. "Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(6), pages 661-673, July.
  113. Mennini, Francesco Saverio & Gitto, Lara, 2022. "Approaches to Estimating Indirect Costs in Healthcare: Motivations for Choice," MPRA Paper 112129, University Library of Munich, Germany.
  114. Werner B.F. Brouwer & Frans F.H. Rutten, 2003. "The missing link: on the line between C and E," Health Economics, John Wiley & Sons, Ltd., vol. 12(8), pages 629-636, August.
  115. Gudrun Biffl & Thomas Leoni, 2008. "Arbeitsbedingte Erkrankungen. Schätzung der gesamtwirtschaftlichen Kosten mit dem Schwerpunkt auf physischen Belastungen," WIFO Studies, WIFO, number 35099, April.
  116. Milton C. Weinstein & Joanna E. Siegel & Alan M. Garber & Joseph Lipscomb & Bryan R. Luce & Willard G. Manning & George W. Torrance, 1997. "Productivity costs, time costs and health‐related quality of life: a response to the Erasmus Group," Health Economics, John Wiley & Sons, Ltd., vol. 6(5), pages 505-510, September.
  117. Josue Mbonigaba & Wilfred Gbenga Akinola, 2021. "Productivity and Income Effect of Breast Cancer among Women in Southwestern Nigeria," Economies, MDPI, vol. 9(3), pages 1-19, September.
  118. Krol, Marieke & Brouwer, Werner B.F. & Severens, Johan L. & Kaper, Janneke & Evers, Silvia M.A.A., 2012. "Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects," Social Science & Medicine, Elsevier, vol. 75(11), pages 1981-1988.
  119. Hansen, Kristian S. & Moreno-Ternero, Juan D. & Østerdal, Lars P., 2024. "Quality- and productivity-adjusted life years: From QALYs to PALYs and beyond," Journal of Health Economics, Elsevier, vol. 95(C).
  120. Orsolya Balogh & Valentin Brodszky & László Gulácsi & Emese Herédi & Krisztina Herszényi & Hajnalka Jókai & Sarolta Kárpáti & Petra Baji & Éva Remenyik & Andrea Szegedi & Péter Holló, 2014. "Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(1), pages 101-109, May.
  121. Tim A Kanters & Clazien A M Bouwmans & Naomi van der Linden & Siok Swan Tan & Leona Hakkaart-van Roijen, 2017. "Update of the Dutch manual for costing studies in health care," PLOS ONE, Public Library of Science, vol. 12(11), pages 1-11, November.
  122. Michał Jakubczyk & Beata Koń, 2017. "The impact of firms’ adjustments on the indirect cost of illness," International Journal of Health Economics and Management, Springer, vol. 17(3), pages 377-394, September.
  123. Hanly, Paul & Ortega Ortega, Marta & Pearce, Alison & Soerjomataram, Isabelle & Sharp, Linda, 2020. "Advances in the methodological approach to friction period estimation: A European perspective," Social Science & Medicine, Elsevier, vol. 264(C).
  124. Rachel Meacock & Nicola Dale & Mark Harrison, 2013. "The Humanistic and Economic Burden of Systemic Lupus Erythematosus," PharmacoEconomics, Springer, vol. 31(1), pages 49-61, January.
  125. Jason Foo & Sarah H Landis & Joe Maskell & Yeon-Mok Oh & Thys van der Molen & MeiLan K Han & David M Mannino & Masakazu Ichinose & Yogesh Punekar, 2016. "Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries," PLOS ONE, Public Library of Science, vol. 11(4), pages 1-15, April.
  126. Gisela Kobelt & Jenny Berg & Peter Lindgren & Bengt Jönsson, 2006. "Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(2), pages 5-13, July.
  127. Christopher McCabe, 2019. "Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution," PharmacoEconomics, Springer, vol. 37(4), pages 457-460, April.
  128. Gamero-Burón, Carlos, 2010. "Evaluación del coste por pérdida de jornadas laborales asociado al estrés laboral: propuesta para España/Assessing the Cost of Lost Working Days Associated With Job Stress: A Proposal for Spain," Estudios de Economia Aplicada, Estudios de Economia Aplicada, vol. 28, pages 689(20á)-68, Diciembre.
  129. Norman, Richard & Haas, Marion & Wilcken, Bridget, 2009. "International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions," Health Policy, Elsevier, vol. 89(3), pages 252-260, March.
  130. Shankar Prinja & Jagnoor Jagnoor & Deepshikha Sharma & Sameer Aggarwal & Swati Katoch & P V M Lakshmi & Rebecca Ivers, 2019. "Out-of-pocket expenditure and catastrophic health expenditure for hospitalization due to injuries in public sector hospitals in North India," PLOS ONE, Public Library of Science, vol. 14(11), pages 1-17, November.
  131. Xiaodi Xie & Jürgen Rehrn & Eric Single & Lynda Robson & Josh Paul, 1998. "The economic costs of illicit drug use in Ontario, 1992," Health Economics, John Wiley & Sons, Ltd., vol. 7(1), pages 81-85, February.
  132. Santini, Ziggi Ivan & Thygesen, Lau Caspar & Koyanagi, Ai & Stewart-Brown, Sarah & Meilstrup, Charlotte & Nielsen, Line & Olsen, Kim Rose & Birkjær, Michael & McDaid, David & Koushede, Vibeke & Ekholm, 2022. "Economics of mental wellbeing: a prospective study estimating associated productivity costs due to sickness absence from the workplace in Denmark," LSE Research Online Documents on Economics 116690, London School of Economics and Political Science, LSE Library.
  133. Oliver Damm & Martin Eichner & Markus Rose & Markus Knuf & Peter Wutzler & Johannes Liese & Hagen Krüger & Wolfgang Greiner, 2015. "Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(5), pages 471-488, June.
  134. Werner B.F. Brouwer & Marc A. Koopmanschap & Frans F.H. Rutten, 1997. "Productivity costs in cost‐effectiveness analysis: numerator or denominator: a further discussion," Health Economics, John Wiley & Sons, Ltd., vol. 6(5), pages 511-514, September.
  135. Erik Landfeldt & Niklas Zethraeus & Peter Lindgren, 2019. "Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method," Applied Health Economics and Health Policy, Springer, vol. 17(1), pages 15-24, February.
  136. Brouwer, W. B. F. & van Exel, N. J. A. & Koopmanschap, M. A. & Rutten, F. F. H., 2002. "Productivity costs before and after absence from work: as important as common?," Health Policy, Elsevier, vol. 61(2), pages 173-187, August.
  137. Jonas Steel & Lode Godderis & Jeroen Luyten, 2018. "Methodological Challenges in the Economic Evaluation of Occupational Health and Safety Programmes," IJERPH, MDPI, vol. 15(11), pages 1-12, November.
  138. Jesse Kigozi & Sue Jowett & Martyn Lewis & Pelham Barton & Joanna Coast, 2017. "Valuing productivity costs using the friction‐cost approach: Estimating friction‐period estimates by occupational classifications for the UK," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 1862-1868, December.
  139. Kristian Neovius & Clas Rehnberg & Finn Rasmussen & Martin Neovius, 2012. "Lifetime Productivity Losses Associated with Obesity Status in Early Adulthood," Applied Health Economics and Health Policy, Springer, vol. 10(5), pages 309-317, September.
  140. Petra J. van Enckevort & Marc A. Koopmanschap & Elisabeth M. Tenvergert & Albert Geertsma & Wim van der Bij & Wim J. de Boer & Frans F. H. Rutten, 1997. "Lifetime costs of lung transplantation: estimation of incremental costs," Health Economics, John Wiley & Sons, Ltd., vol. 6(5), pages 479-489, September.
  141. Zaid Chalabi & Sari Kovats, 2014. "Tools for developing adaptation policy to protect human health," Mitigation and Adaptation Strategies for Global Change, Springer, vol. 19(3), pages 309-330, March.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.